Atlas Trials

Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy Subjects

Clinical trial NCT02676596 · COMPLETED

Trial details

NCT number
NCT02676596
Sponsor
Kowa Research Institute, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hyperlipidemia
Start date
2014-04-01
Primary completion
2014-11-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.